You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 23 No. 4, October 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (253)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cortisol Production in Depressive Illness

A Clinical and Biochemical Clarification

Edward J. Sachar, MD; Leon Hellman, MD; David K. Fukushima, PhD; T. F. Gallagher, PhD

Arch Gen Psychiatry. 1970;23(4):289-298.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS paper will attempt to clarify the relation of clinical features of depressive illness to the secretory activity of the adrenal cortex.

The discovery that psychological stress stimulates the anterior pituitary-adrenocortical system1 has led to considerable interest in studying the function of the adrenal cortex in patients with mental illnesses, including depressions. In a recent review paper,2 Sachar pointed out that the extensive literature describing levels of adrenocortical hormones in depressed patients was quite inconsistent, with many reports suggesting elevated corticosteroid levels and other reports suggesting normal corticosteroid levels, some suggesting good correlation of severity of illness with adrenocortical indices, and others reporting poor correlations. It appeared that neglect of several significant control issues had contributed to the apparent diversity in findings. These necessary controls include eliminating all drugs which may interfere with the release of adrenocorticotropic hormone (ACTH), giving the patient enough time to get over . . . [Full Text PDF of this Article]


Author Affiliations

Bronx, NY

From the divisions of psychiatry (Dr. Sachar) and neoplastic medicine (Dr. Hellman), and the Institute for Steroid Research (Drs. Fukushima and Gallagher), Montefiore Hospital and Medical Center, and the departments of psychiatry (Dr. Sachar), medicine (Dr. Hellman), and biochemistry (Drs. Fukushima and Gallagher), Albert Einstein College of Medicine, Bronx, NY.


Footnotes

Accepted for publication Feb 10, 1970.

Reprint requests to Division of Psychiatry, Montefiore Hospital and Medical Center, 111 E 210th St, Bronx, NY 10467 (Dr. Sachar).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.